AstraZeneca Faces Call For Sanctions
Drug maker AstraZeneca wants to derail discovery in the case over antipyschotic Seroquel, creating a "discovery filibuster," according to plaintiffs in the multidistrict litigation....To view the full article, register now.
Already a subscriber? Click here to view full article